Nanoparticles could help block herpes infection

Researchers at Johns Hopkins University say they've developed mucous-penetrating nanoparticles that can get anti-herpes drugs into the vaginal walls and help prevent infection.

The scientists' method, described in Science Translational Medicine, is designed to get around the body's natural mucous defenses, which, while helpful in keeping out infection, also create a barrier to effective drug delivery. To get around the issue, the researchers created nanoparticles that mimic mucous-penetrating viruses, coating them in polyethylene glycol so that they can slip through mucous membranes and enter the skin to deposit herpes-fighting drugs, News Medical reports. The particles are contained in a gel, designed to be applied vaginally.

The researchers tested their discovery on mice, discovering that the nanoparticle formulation tripled the anti-herpes treatment's effectiveness, MyHealthNewsDaily reports. And to be sure, the scientists deliberately chose a weak herpes drug and exposed it to a particulary infectious strain of the virus, finding that the treatment's effectiveness in preventing infection went from 16% with a normal administration to 53% with the nanoparticles.

Next, of course, will be human trials, which head researcher Justin Hanes said could start within a year.

- here's the abstract
- read the News Medical story
- check out MyHealthNewsDaily's report

Suggested Articles

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.

Researchers at Johns Hopkins have changed the structure of a new cancer drug to allow it to more easily pass the blood-brain barrier, giving it access to…

Medtronic’s world-first FDA-approved hybrid closed-loop insulin delivery system might soon face competition, as T1D Exchange has pledged to invest in the…